Which is stronger for cognitive research — Semax or Dihexa?

Dihexa is documented as far more potent by molecular weight in synaptogenesis models. Semax has a broader published literature and a cleaner safety characterization. Research objectives should guide the selection rather than potency alone.

Can Semax and Dihexa be studied together?

Combination protocols exist in the research community, but published combination data is limited. Semax acts primarily via BDNF/NGF; Dihexa via HGF/Met — the pathways are complementary rather than redundant. For research use only.

Where can I find Semax and Dihexa for research use?

Research-grade Semax and Dihexa are available through research peptide suppliers for laboratory and analytical use only. Use code SOL at Live Alpha Labs for 10% off. We may earn from qualifying purchases.

Cognitive research comparison

Semax vs Dihexa: Cognitive Peptide Research Comparison

Short answer: Semax acts on BDNF/NGF neuroprotection pathways (ACTH/MSH analog); Dihexa acts via HGF/Met receptor potentiation and is documented as vastly more potent in synaptogenesis models. They target different pathways and serve different research endpoints within cognitive and neurological research.

Disclosure: This page contains affiliate links. We may earn from qualifying purchases. See our full disclosure.

SemaxACTH/MSH analog

Mechanism: ACTH/MSH 4–7 fragment analog — upregulates BDNF, NGF, and VEGF; modulates dopamine and serotonin
Structure: Heptapeptide (Met-Glu-His-Phe-Pro-Gly-Pro) with Pro-Gly-Pro extension for stability
Half-life context: ~20 minutes in plasma; longer CNS effect documented
Research profile: Neuroprotection, memory consolidation, and attention pathway studies; ischemia models
Published literature: Extensive — developed in Soviet-era research, now well-characterized
Administration in research: Intranasal route well-documented alongside subcutaneous in preclinical models

DihexaAngiotensin IV analog

Mechanism: Angiotensin IV / HGF (hepatocyte growth factor) potentiator via Met receptor — drives synaptogenesis
Structure: N-hexanoic acid-Tyr-Ile-His-Pro-Phe-OH (6-amino acid angiotensin IV analog)
Half-life context: Extended CNS retention — hours to days in neural tissue models
Research profile: Synaptogenesis, cognitive-function recovery, and dendritic spine density studies
Potency context: Estimated 10 million times more potent than BDNF in synaptogenesis models (Washington State University research)
Administration in research: Oral and subcutaneous routes documented; crosses blood-brain barrier

Research Profile Comparison

Criteria	Semax	Dihexa
Primary pathway	BDNF / NGF	HGF / Met receptor
Research focus	Neuroprotection, attention	Synaptogenesis, memory recovery
Published literature volume	Extensive	Emerging (WSU research, 2012+)
Relative potency	Standard nootropic range	Exceptionally potent by molecular weight

Current research deal — use code SOL

10% off Semax, Dihexa, and cognitive research peptides at Live Alpha Labs. Credit cards accepted. For research use only. We may earn from qualifying purchases.

Claim 10% off at Live Alpha →View Deals Hub

Related comparison

Semax vs Selank Comparison

Category hub

Cognitive and Neuro Research Hub

Deep dive

Semax Research Guide

All current offers

Peptide Deals + Research News Hub

Frequently Asked Questions

Semax is an ACTH/MSH analog that primarily acts on BDNF and NGF pathways, with a well-established nootropic research base. Dihexa is an angiotensin IV analog that potentiates HGF/Met signaling — it is estimated to be 10 million times more potent than BDNF in synaptogenesis models. They target very different upstream pathways to cognitive-research endpoints.

Semax vs Dihexa: Cognitive Peptide Research Comparison

Disclosure: This page contains affiliate links. We may earn from qualifying purchases. See our full disclosure.

Criteria

Semax

Dihexa

Primary pathway

BDNF / NGF

HGF / Met receptor

Research focus

Neuroprotection, attention

Synaptogenesis, memory recovery

Published literature volume

Extensive

Emerging (WSU research, 2012+)

Relative potency

Standard nootropic range

Exceptionally potent by molecular weight

Frequently Asked Questions